MedTrace Logo

Symptom Management for Irritable Bowel Syndrome

NCT02079857 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 183

Last updated 2020-07-28

No results posted yet for this study

Summary

The objective of this study is to test the efficacy of a symptom management treatment strategy, Acupuncture/Moxibustion (Acu/Moxa), to improve the symptoms associated with Irritable Bowel Syndrome (IBS) in adults.

Conditions

  • Irritable Bowel Syndrome

Interventions

OTHER

Standard protocol

Subjects will receive a standard treatment

OTHER

Individualized protocol

Subjects will receive an individualized treatment

OTHER

Sham acupuncture/Placebo moxa

Subjects will receive sham acupuncture/placebo moxa

Sponsors & Collaborators

  • National Institute of Nursing Research (NINR)

    collaborator NIH

  • NYU Langone Health

    lead OTHER

Principal Investigators

  • Joyce K Anastasi, PhD · New York University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2019-11-01
Completion
2019-11-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02079857 on ClinicalTrials.gov